Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
University of Nebraska
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Heidelberg University